+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-02-03Number of Pages: 105

Dermatology Diagnostic Devices and Therapeutics Market (Devices and Drug Class) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Dermatology is a branch of medical science that deals with examination and treatment of various disorders and diseases related to the skin, hair, nails, including its surgical aspect. The stakeholders of this market report comprise established original equipment and pharmaceutical product manufacturers, product distributors, and new players who wish to enter the global dermatology diagnostic devices and therapeutics market. 

This report provides a complete analysis of the global dermatology diagnostic devices and therapeutics market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the dermatology diagnostic device and dermatology market in terms of current and future market size along with growth rate. 

The market overview segment provides thorough information on the trends in the usage pattern of various diagnostic devices and therapeutics for dermatology, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this study to provide analysis about the level of competition within the dermatology diagnostic devices and therapeutics market. Competitive intelligence tools such as market attractiveness analysis have also been included in the market overview section of the report to deliver a clear understanding of the most attractive and fastest growing device segment, drug class and region globally for dermatology diagnostic devices and therapeutics. 

Market share analysis thus provided in this study is in context with major players of dermatology diagnostic devices and dermatology therapeutics operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the dermatology diagnostic devices and therapeutics market. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes tabular representation of phase I and phase II candidates along with sales forecast potential drugs that are undergoing phase III clinical trials and are expected to be marketed during the forecast period. 

The global dermatology diagnostic devices and therapeutics market has been segmented based on various dermatology diagnostic devices, drug classes used for treating dermatology disorders, and geographies. Based on dermatology diagnostic products the market has been categorized into dermatoscopes, microscopes & trichoscopes, and imaging equipment. Based on drug class the dermatology therapeutics market has been segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppresants, biologics. The market size for the period from 2013 to 2023 has been provided for each of the devices and therapeutics categories mentioned above in terms of US$ Mn. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 (for therapeutics forecast period is from 2013 to 2018 and 2018 to 2023) has also been provided. 

Geographically, the dermatology diagnostic devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, India, Australia, and Rest of Asia Pacific; Latin America into Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Kuwait, UAE, Saudi Arabia, and rest of MENA; and Rest of the world. The market revenue of dermatology diagnostic devices and therapeutics for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD Mn, has been explained in the geography section of the report. 

This market study concludes with profiles of key players in the global dermatology diagnostic devices and dermatology market. The report summarizes the companies in terms of overview, financial overview, product and services portfolio, key business strategies, and recent developments. The major players profiled in the section are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc. 

The global dermatology diagnostic devices and therapeutics market has been segmented as follows:

Dermatology Diagnostic Devices Market, by Products

  • Dermatoscopes
  • Microscopes and Trichoscopes
  • Imaging Equipment

Dermatology Therapeutics Market, by Drug Class

  • Antibacterials
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppresants
  • Biologics

Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3

  • Tabular Representation: Phase 1 and Phase 2 Candidates
  • Pipeline Analysis and Forecast: Phase 3
    • LAS41008
    • Ixekizumab
    • Dupilumab
    • CD5789
    • IDP-118

Dermatology Diagnostic Devices and Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa (MENA)
    • Egypt
    • Kuwait
    • UAE
    • Saudi Arabia
    • Rest of MENA
  • Rest of the World (RoW)


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2013–2023 (US$ Mn)
2.2 Global Dermatology Diagnostic Devices Market, by Product, 2014 (US$ Mn)
2.3 Global Dermatology Therapeutics Market, by Drug Class, 2014 (US$ Mn)
2.4 Global Market Share by Geography (Diagnostic Devices), 2014 and 2023 (Value %)
2.5 Global Market Share by Geography (Therapeutics), 2014 and 2023 (Value %)
2.6 Dermatology Diagnostic Devices Market Snapshot
2.7 Dermatology Therapeutics Market Snapshot

Chapter 3 Dermatology Diagnostic Devices and Therapeutics Market Overview
3.1 Market Overview
3.2 Market Drivers
     3.2.1 Driver 1 - Rising prevalence of acute and chronic skin disorders
     3.2.2 Driver 2 - Changing patient pool demographics and increasing geriatric population
            3.2.2.1 Percentage of Population (for U.S., China, Japan, and India) over the age of 65: 1980–2050 
            3.2.2.2 Global Percentage Change in the World’s Population by Age: 2010 – 2050
3.3 Restraints
     3.3.1 Restraint 1 - Implementation of the Affordable Care Act and medical device tax
     3.3.2 Restraint 2 -Patent expirations of major drugs during the forecast period expected to impede market growth
3.4 Opportunities
     3.4.1 Opportunity 1 - Disposable income and growing patient pool in emerging markets
3.5 Porter’s Five Forces Analysis
3.6 Company Market Share
3.7 Market Attractiveness Analysis
3.8 Overview of Skin Diseases

Chapter 4 Market Segmentation – By Products
4.1 Introduction
     4.1.1 Global Dermatology Diagnostic Devices Market, by Product, 2013–2023 (US$ Mn)
4.2 Global Dermatoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)
4.3 Global Microscopes and Trichoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)
4.4 Global Imaging Equipment Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)

Chapter 5 Market Segmentation – By Drug Class
5.1 Introduction
     5.1.1 Global Dermatology Therapeutics Market, by Drug Class, 2013–2023 (US$ Mn)
5.2 Global Antibacterials for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.3 Global Antifungal Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.4 Global Antiviral Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.5 Global Corticosteroids for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.6 Global Retinoids for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.7 Global Immunosuppresants for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.8 Global Biologics for Dermatology Market Revenue, 2013–2023 (US$ Mn)

Chapter 6 Market Segmentation – By Pipeline Assessment
6.1 Global Dermatology Therapeutics Market: Pipeline Overview, Phase I, II,and III
6.2 Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2023 (US$ Mn) 

Chapter 7 Market Segmentation – By Region
7.1 Overview
     7.1.1 Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2013–2023 (US$ Mn)
     7.1.2 Global Dermatology Therapeutics Market Revenue, by Geography, 2013–2023 (US$ Mn)
7.2 North America 
     7.2.1 North America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.2.2 North America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.3 Europe
     7.3.1 Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.3.2 Europe Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.4 Asia Pacific
     7.4.1 APAC Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.4.2 APAC Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.5 Latin America
     7.5.1 Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.5.2 Latin America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.6 Middle East & North Africa
     7.6.1 MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.6.2 MENA Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.7 Rest of the World
     7.7.1 RoW Dermatology Diagnostic Devices Market Revenue, 2013–2023 (US$ Mn)
     7.7.2 RoW Dermatology Therapeutics Market Revenue, 2013–2023 (US$ Mn)

Chapter 8 Historical Snapshot and Current Trends

Chapter 9 Company Profiles
9.1 Agfa-Gevaert N.V.
9.2 Astellas Pharma, Inc.
9.3 Cutera, Inc.
9.4 Dino-Lite Europe/IDCP B.V.
9.5 Galderma S.A.
9.6 Genentech, a Roche Company 
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
9.8 LEO Pharma A/S
9.9 Michelson Diagnostics Ltd.
9.10 Novartis International AG
9.11 Valeant Pharmaceuticals International, Inc.

Chronic and acute skin diseases such as acne, rosacea, psoriasis, squamous cell carcinoma, eczema, dermatitis, and pruritus are the major health concerns worldwide and account for a large portion of health care associated financial burden. These permeate all cultures, occur at all ages, and affect between 30% and 70% of individuals globally, with even higher rates in at-risk subpopulations. Key elements such as rising prevalence of acute and chronic skin disorders and changing patient pool demographics along with increasing geriatric population are driving the growth of the global dermatology diagnostic devices and therapeutics market. However, certain factors such as implementation of the Affordable Care Act and upcoming patent expirations of the major drugs during the forecast period are expected to impede the market growth.

Based on dermatology diagnostic products the market has been categorized into dermatoscopes, microscopes & trichoscopes, and imaging equipment. In terms of revenue, imaging equipment segment that included devices such as ultrasound imaging devices, automated dermatology diagnostic devices, and digital pathology systems dominated the market in 2014 and is expected to grow at the fastest CAGR of over 7% during the forecast period due to high price (usually ranges between US$ 2000 and US$ 5000) and precise results. Moreover, other companies participating in this segment are trying to innovate and introduce advanced skin analyzers that can measure the quality of the skin and provide useful remedies. For instance, Japan-based global technology company, Sony Corporation has developed a portable hand-held skin-measuring device called BeautyExplorer that can analyze under the skin for any unwanted blemishes, pores, brightness or pigmentation in the skin. The company will release the device in March, 2016 and is aimed at professional customers like beauty salons and cosmetic manufacturers.

The dermatology therapeutics market has been categorized by various drug class use for treating skin disorders. In terms of drugs, the dermatology therapeutics market is segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppresants, and biologics. Antibacterials and biologics are the largest drug segments in this category. Better patient compliance, commendable effectiveness, and low severe side effects are few of the major factors that are boosting the growth of the segments. However, upcoming patent cliff of major blockbuster biologics such as Humira (marketed by AbbVie, Inc. and expiring in December 2016); Remicade (marketed by Janssen Biotech, Inc. and expiring in December 2018), and Stelara (marketed by Janssen Biotech, Inc. and expiring in September 2023) are one of the major factor that might reduce the market growth of biologics in the near future. Additionally, the pipeline analysis segment includes the sales forecast of potential phase III molecules such as Dupilumab, Ixekizumab, and LAS41008 along with projected growth rates.

Geographically, North America accounted for the largest share of both the global dermatology diagnostic devices as well as global dermatology therapeutics market in 2014. Elements attributed to the dominant position of North America in dermatology diagnostic devices and therapeutics market are rising incidence of skin disorders such as skin melanoma, psoriasis, and bacterial infections among population, and increased access to health care. Also, North America is expected to be the fastest growth region for the dermatology diagnostic devices market during the forecast period. However, Asia Pacific is projected to witness the fastest and highest growth during the forecast period for dermatology therapeutics market. Key elements such as rising disposable income among population in various emerging countries, phenomenally increasing base of patient population suffering from skin disorders, and higher demand for safe and effective medication would heighten the growth of dermatology therapeutics market in Asia Pacific. 

The global dermatology diagnostic devices and therapeutics market is highly dynamic and competitive. The major companies currently operating in the dermatology diagnostic devices and therapeutics market are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc. Superior distribution channels, easy commercial availability of products, and ample supply competencies are the other key factors that play an important role in determining the market position of these players.

 

dermatology-diagnostic-devices-therapeutics-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries